was diagnosed earlier in life are at a greater risk for cardiovascular diseases and may benefit from intensive antihypertensive therapy.Age-related elevation in blood pressure begins earlier in life and faster in women than in men, particularly in the presence of cardiometabolic risk factors such as T2D .included individuals with T2D who were randomly assigned to receive either intensive or standard antihypertensive treatment targets.
Intensive vs standard antihypertensive treatment attenuated the excess CVD risk associated with early-diagnosed hypertension by 35% in women for each decade earlier at hypertension diagnosis, predominantly observed in women who received standard rather than intensive antihypertensive treatment."Women with type 2 diabetes whose hypertension was diagnosed earlier in life could substantially benefit from intensive over standard antihypertensive treatment," wrote the authors.
Diabetes Mellitus Type Ii Type 2 Diabetes Type 2 DM T2DM T2D Hypertension Antihypertensive Heart Failure Cardiometabolic Risk Cardiometabolic Risk Factors Blood Atherosclerotic Heart Disease Atherosclerotic Cardiovascular Disease Coronary Heart Disease Ischemic Heart Disease Coronary Artery Disease CV Risk Cardiovascular Risk CV Risk Factors
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
SGLT2 Inhibitors Reduce Anemia Risk in Concomitant T2D, CKDInitiating treatment with SGLT2 inhibitors vs GLP-1 RAs was linked to a 19% reduced risk for composite anemia outcomes in patients with T2D and CKD stages I-III.
Source: Medscape - 🏆 386. / 55 Read more »
Energy-Restricted Diet Twice Weekly Tops Exercise in T2DFollowing a medically supervised energy-restricted diet 2 days a week could improve glycemic control in patients with overweight or mild obesity and type 2 diabetes.
Source: Medscape - 🏆 386. / 55 Read more »
FDA Approves ide-cel for Adults with Relapsed or Refractory Multiple MyelomaThe FDA has approved ide-cel, a chimeric antigen receptor (CAR) T-cell therapy, for adults with relapsed or refractory multiple myeloma after two or more prior lines of therapy. The approval expands the therapy's indications to earlier lines of treatment after exposure to other main therapy classes.
Source: Medscape - 🏆 386. / 55 Read more »
iGlarLixi Safe and Effective in Inadequately Controlled Type 2 DiabetesA once-daily injectable therapy of a fixed-ratio combination of insulin glargine and lixisenatide improved glycemic control, with low rates of hypoglycemia, in people with T2D in a real-world setting.
Source: Medscape - 🏆 386. / 55 Read more »
Securing competitiveness of energy-intensive industries through relocation: The pulling power of renewablesCountries with limited potential for renewables could save up to 20 percent of costs for green steel and up to 40 percent for green chemicals from green hydrogen if they relocated their energy-intensive production and would import from countries where renewable energy is cheaper.
Source: ScienceDaily - 🏆 452. / 53 Read more »
Truck Manufacturers A More Carbon Intensive Investment Than Oil, Steel Or Cars — StudyTruck Manufacturers A More Carbon Intensive Investment Than Oil, Steel Or Cars – Study emissions 50% higher than what they report to investor
Source: cleantechnica - 🏆 565. / 51 Read more »